Tests magnesium with prochlorperazine for migraine pain in emergency patients
Tests magnesium added to prochlorperazine for migraine pain in adults.
Plain-language title generated from the registry record
Registry title: Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Key facts
- Where
- Oak Lawn, United StatesSee the site
- Phase
- Phase 3
Where in United States
- Advocate Christ Medical Center Emergency DepartmentOak Lawn, United StatesTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Wake Forest University Health Sciences
- Trial code
- NCT06904287
- Record updated
- 22 January 2026
- Original description
The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.Read full original descriptionShow less
Evaluating the Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines in the Emergency Department
The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.
Inclusion: Age ≥ 18 years or older; Able to provide informed consent; English speaking; Primary diagnosis of migraine. Patient with a previous diagnosis of migraine, who experience headaches with typical migraine features (e.g at least 2-3 of the following: recurrent, unilateral, pounding or throbbing in nature, associated with nausea), AND with a clinical exclusion of migraine mimics.
Exclusion: Consumption of study drug within 48 hours prior to enrollment; Previously enrolled in this trial during a different patient encounter; Allergy or sensitivity to study drug; Stated history of renal insufficiency; Documented history of myasthenia gravis; Pregnancy defined as a positive urine HCG.